The Central Hospital of Shaoyang

Shaoyang

2 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Metastatic Breast Cancer, Monoclonal Antibody

Studies at this site

• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now